Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Mar 25

PMID 35327366

Authors

Konstantinos Gousias

Theocharis Theocharous

Matthias Simon

Affiliations

Soon will be listed here.

Abstract

Cells of glioblastoma, the most frequent primary malignant brain tumor, are characterized by their rapid growth and infiltration of adjacent healthy brain parenchyma, which reflects their aggressive biological behavior. In order to maintain their excessive proliferation and invasion, glioblastomas exploit the innate biological capacities of the patients suffering from this tumor. The pathways involved in cell cycle regulation and apoptosis are the mechanisms most commonly affected. The following work reviews the regulatory pathways of cell growth in general as well as the dysregulated cell cycle and apoptosis relevant mechanisms observed in glioblastomas. We then describe the molecular targeting of the current established adjuvant therapy and present ongoing trials or completed studies on specific promising therapeutic agents that induce cell cycle arrest and apoptosis of glioblastoma cells.

Citing Articles

PEGylated iron oxide-gold core-shell nanoparticles for tumor-targeted delivery of Rapamycin.

Koothradan S, Nayeem S, Elyas K 3 Biotech. 2024; 15(1):23.

PMID: 39735611 PMC: 11669639. DOI: 10.1007/s13205-024-04189-y.

Doublecortin regulates the mitochondrial-dependent apoptosis in glioma via Rho-A/Net-1/p38-MAPK signaling.

Nadeem I, Han Z, Xiaoliang H, Adzraku S, Kambey P, Kanwore K Mol Med. 2024; 30(1):272.

PMID: 39719558 PMC: 11668075. DOI: 10.1186/s10020-024-01021-4.

Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based Approach.

Kaynar A, Kim W, Ceyhan A, Zhang C, Uhlen M, Turkez H Biomedicines. 2024; 12(10).

PMID: 39457550 PMC: 11504402. DOI: 10.3390/biomedicines12102237.

Regulation of autophagy by non-coding RNAs in human glioblastoma.

Molavand M, Ebrahimnezhade N, Kiani A, Yousefi B, Nazari A, Majidinia M Med Oncol. 2024; 41(11):260.

PMID: 39375229 DOI: 10.1007/s12032-024-02513-3.

Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood-brain-barrier in a glioblastoma model.

Madani F, Morovvati H, Webster T, Najaf Asaadi S, Rezayat S, Hadjighassem M Sci Rep. 2024; 14(1):19516.

PMID: 39174603 PMC: 11341868. DOI: 10.1038/s41598-024-69888-1.

References

Lin W, Liu Y, Lee M, Tang C, Wu G, Chang Y . From GWAS to drug screening: repurposing antipsychotics for glioblastoma. J Transl Med. 2022; 20(1):70. PMC: 8815269. DOI: 10.1186/s12967-021-03209-2. View

Porta C, Paglino C, Mosca A . Targeting PI3K/Akt/mTOR Signaling in Cancer. Front Oncol. 2014; 4:64. PMC: 3995050. DOI: 10.3389/fonc.2014.00064. View

Hahn A, Jones J, Meyer T . Quantitative analysis of cell cycle phase durations and PC12 differentiation using fluorescent biosensors. Cell Cycle. 2009; 8(7):1044-52. PMC: 2668240. DOI: 10.4161/cc.8.7.8042. View

Dey A, Nishiyama A, Karpova T, McNally J, Ozato K . Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol Biol Cell. 2009; 20(23):4899-909. PMC: 2785733. DOI: 10.1091/mbc.e09-05-0380. View

Nachmias B, Schimmer A . Targeting nuclear import and export in hematological malignancies. Leukemia. 2020; 34(11):2875-2886. PMC: 7584478. DOI: 10.1038/s41375-020-0958-y. View

Fukaya R, Ohta S, Yaguchi T, Matsuzaki Y, Sugihara E, Okano H . MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53. Cancer Res. 2016; 76(9):2813-23. DOI: 10.1158/0008-5472.CAN-15-1011. View

Gousias K, Becker A, Simon M, Niehusmann P . Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas. J Neurooncol. 2012; 109(3):545-53. DOI: 10.1007/s11060-012-0924-2. View

Nakamura M, Watanabe T, Klangby U, Asker C, Wiman K, Yonekawa Y . p14ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol. 2001; 11(2):159-68. PMC: 8098332. DOI: 10.1111/j.1750-3639.2001.tb00388.x. View

Gareev I, Beylerli O, Liang Y, Xiang H, Liu C, Xu X . The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors. Front Cell Dev Biol. 2021; 9:740303. PMC: 8529124. DOI: 10.3389/fcell.2021.740303. View

10.

Riemenschneider M, Buschges R, Wolter M, Reifenberger J, Bostrom J, Kraus J . Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res. 2000; 59(24):6091-6. View

11.

Cheung K, Kim C, Zhou M . The Functions of BET Proteins in Gene Transcription of Biology and Diseases. Front Mol Biosci. 2021; 8:728777. PMC: 8446420. DOI: 10.3389/fmolb.2021.728777. View

12.

Stummer W, Pichlmeier U, Meinel T, Wiestler O, Zanella F, Reulen H . Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7(5):392-401. DOI: 10.1016/S1470-2045(06)70665-9. View

13.

Smith D, Shimamura T, Barbera S, Bejcek B . NF-kappaB controls growth of glioblastomas/astrocytomas. Mol Cell Biochem. 2007; 307(1-2):141-7. DOI: 10.1007/s11010-007-9593-4. View

14.

Simon M, Hosen I, Gousias K, Rachakonda S, Heidenreich B, Gessi M . TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas. Neuro Oncol. 2014; 17(1):45-52. PMC: 4483052. DOI: 10.1093/neuonc/nou158. View

15.

Alexiou G, Lazari D, Markopoulos G, Vartholomatos E, Hodaj E, Galani V . Moschamine inhibits proliferation of glioblastoma cells via cell cycle arrest and apoptosis. Tumour Biol. 2017; 39(5):1010428317705744. DOI: 10.1177/1010428317705744. View

16.

Nguyen L, Searle K, Jerzak K . Central nervous system-specific efficacy of CDK4/6 inhibitors in randomized controlled trials for metastatic breast cancer. Oncotarget. 2019; 10(59):6317-6322. PMC: 6824870. DOI: 10.18632/oncotarget.27238. View

17.

Duffy M, Synnott N, OGrady S, Crown J . Targeting p53 for the treatment of cancer. Semin Cancer Biol. 2020; 79:58-67. DOI: 10.1016/j.semcancer.2020.07.005. View

18.

Alptekin M, Eroglu S, Tutar E, Sencan S, Geyik M, Ulasli M . Gene expressions of TRP channels in glioblastoma multiforme and relation with survival. Tumour Biol. 2015; 36(12):9209-13. DOI: 10.1007/s13277-015-3577-x. View

19.

Reifenberger G, Liu L, Ichimura K, Schmidt E, Collins V . Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 1993; 53(12):2736-9. View

20.

Gera N, Yang A, Holtzman T, Lee S, Wong E, Swanson K . Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS One. 2015; 10(5):e0125269. PMC: 4444126. DOI: 10.1371/journal.pone.0125269. View